Showing results (101-110 of 150) with videos related to
Sort By:
Pageof 15
European Journal of Cancer (Oxford, England : 1990)|November 10, 2024
Prospective study on Oncotype DX® assay to assess recurrence risk in early ER-positive HER2-negative breast cancer patients with uncertain biological behavior by standard parameters and its impact on treatment recommendation: The POST trialLuca Livraghi, Francesca Martella, Matteo Ghilli, et al.NPJ Breast Cancer|June 29, 2021
Composite risk and benefit from adjuvant dose-dense chemotherapy in hormone receptor-positive breast cancerFabio Puglisi, Lorenzo Gerratana, Matteo Lambertini, et al.Breast (Edinburgh, Scotland)|June 27, 2026
Dose-dense adjuvant chemotherapy in HER2-low breast cancer: An exploratory analysis of the GIM2 trialChiara Molinelli, Virginia Delucchi, Eva Blondeaux, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2010
Excellent outcome with reduced treatment in infants with nonmetastatic and unresectable neuroblastoma without MYCN amplification: results of the prospective INES 99.1Hervé Rubie, Bruno De Bernardi, Mary Gerrard, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2025
Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 TrialHarriet Johansson, Debora Macis, Martino Oliva, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 20, 2021
Effect Modifiers of Low-Dose Tamoxifen in a Randomized Trial in Breast Noninvasive DiseaseAndrea DeCensi, Matteo Puntoni, Harriet Johansson, et al.European Journal of Cancer (Oxford, England : 1990)|February 9, 2019
Phase II randomised study of maintenance treatment with bevacizumab or bevacizumab plus metronomic chemotherapy after first-line induction with FOLFOXIRI plus Bevacizumab for metastatic colorectal cancer patients: the MOMA trialChiara Cremolini, Federica Marmorino, Francesca Bergamo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 12, 2019
Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Local and Contralateral Recurrence in Breast Intraepithelial NeoplasiaAndrea DeCensi, Matteo Puntoni, Aliana Guerrieri-Gonzaga, et al.Frontiers in Medicine|January 31, 2022
ERANET JTC 2011: Submission and Activation of an International Academic Translational Project in Advanced Breast Cancer. Experience From the ET-FES StudyManuela Monti, Tom Degenhardt, Etienne Brain, et al.Oncotarget|March 1, 2018
<i>DPYD</i> and <i>UGT1A1</i> genotyping to predict adverse events during first-line FOLFIRI or FOLFOXIRI plus bevacizumab in metastatic colorectal cancerChiara Cremolini, Marzia Del Re, Carlotta Antoniotti, et al.Pageof 15